logo
Grandad ‘suffocated to death' on trolley in front of his wife and daughter in ‘chaotic' A&E corridor after 18-hour wait

Grandad ‘suffocated to death' on trolley in front of his wife and daughter in ‘chaotic' A&E corridor after 18-hour wait

The Sun3 days ago
GRAHAM Millward "suffocated to death" on a trolley in an A&E corridor in front of his wife and daughter.
The grandad had been deprived of oxygen at Telford's Princess Royal Hospital following an 18-hour wait outside in an ambulance receiving area.
2
2
"My father did not deserve this," Paula Millward, 60, said. "He was deprived of a dignified passing and I was forced to watch him take his final breaths."
An inquest heard the 87-year-old had been admitted to the hospital on January 9 this year after paramedics were called to his nursing home in Wellington, Shropshire.
But on arrival at the hospital, there was no room on a ward, so Graham was forced to wait in the ambulance receiving area for a shocking 18 hours.
Paula, from Telford said when he was finally taken to A&E, there was still no cubicle ready and staff failed to attach his oxygen properly, leaving him "gasping for air."
The retired welder never made it onto a ward for further treatment and died on a hospital trolley inside the busy A&E department.
Paula said she was then forced to watch her dad's final gasps for air after bungling hospital staff failed to reattach his oxygen.
She said the distress the event has caused is "unforgivable."
"He had been poorly and he had been in and out of hospital, but we fully expected him to be coming home and the hospital report confirmed he should have," she explained.
"He spent an hour on the ambulance on arrival before being taken to the ambulance receiving area, which is basically a glorified porter cabin.
"He was given oxygen, but when he was finally moved 18 hours later, they didn't attach the pipe properly and he still had the face mask on, so it restricted his breathing more.
Boy, 6, 'kills premature newborn baby after dropping infant on floor like a doll when left to roam maternity unit'
"He should have been taken to resus, but instead he was taken to a cubicle, which was already occupied.
"So instead he was in a corridor surrounded by chaos in a busy A&E department, with no dignity at all.
"I said to a nurse 'Is my dad OK?' and she took one look at him and said they needed to get screens around him straight away.
"We basically had to watch him gasping for air before he suffocated to death in front of us.
She added: "My sister and his granddaughter who live away were robbed of the time to get to him.
"He was a lovely family man and very popular. So many people turned out for his funeral but the way he was treated was unforgivable."
Shropshire Coroner's Court heard Graham's death was "more likely than not" sped up by a lack of oxygen therapy.
How oxygen therapy works and why it's critical
Oxygen therapy is a medical treatment that provides extra oxygen to patients who have difficulty breathing or low blood oxygen levels.
It helps ensure vital organs like the brain and heart receive enough oxygen to function properly.
Oxygen is usually delivered through masks or nasal tubes connected to oxygen tanks or hospital pipelines.
Proper fitting and continuous delivery are essential because even brief interruptions or poor attachment can leave patients gasping for air.
For people with conditions like pneumonia, chronic lung disease, or severe infections, oxygen therapy can be life-saving.
Delays or failures in providing oxygen increase the risk of serious complications and can hasten death, making it a critical part of hospital care.
Source: NHS and British Thoracic Society
The grandfather-of-one had been "in and out" of Princess Royal Hospital and had a number of medical conditions, including pneumonia.
But his death was "hastened" due to the failure to provide oxygen, meaning they were "robbed" of the chance to say their goodbyes.
'Hastened his passing'
A statement from a doctor at the hospital was read to the coroner's court.
He said there was a failure to deliver oxygen therapy when it should have been given, and that it was "more likely than not" the error would have caused Graham's "distress" and "hastened his passing".
John Ellery, senior coroner for Shropshire, Telford and Wrekin, recorded a narrative conclusion that Graham's death was of natural causes, hastened with additional distress.
Dr John Jones, medical director at Shrewsbury and Telford Hospitals Trust, said: "We would like to offer our deepest condolences to the family of Graham and apologise for the care he received.
"We are committed to providing the best possible care and we are taking action to address the findings of a full internal investigation, including a review of the staff training for the transfer of patients receiving bottled oxygen.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

I was cured of one of the deadliest forms of cancer after trialling a new drug... my brain cancer is gone
I was cured of one of the deadliest forms of cancer after trialling a new drug... my brain cancer is gone

Daily Mail​

timean hour ago

  • Daily Mail​

I was cured of one of the deadliest forms of cancer after trialling a new drug... my brain cancer is gone

A father who suffered with the world's deadliest form of brain cancer has been cleared after he underwent an experimental treatment. Ben Trotman, 43, who was diagnosed with glioblastoma in October 2022, is now showing no signs of the disease after being administered an immunotherapy drug in a world first two years ago. Most patients with the aggressive form of brain cancer typically die within 12-to-18 months. Consultant medical oncologist, Dr Paul Mulholland, who is leading the new trial and treated Mr Trotman, said: 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans. 'We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay – and it has so far, which we are delighted to see.' Mr Trotman married his wife Emily two months after the immunotherapy treatment in 2023, and in April, his daughter Mabel was born. The father-of-one said: 'Getting this diagnosis was the most traumatic experience. We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. 'Had we not met Dr Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation.' Ben Trotman, 43, who was diagnosed with glioblastoma in October 2022, is now showing no signs of the disease after being administered an immunotherapy drug in a world first two years ago Mr Trotman went on to have the current standard treatment of radiotherapy and chemotherapy. He also undergoes quarterly cans, which continue to return clear. 'We obviously don't know what the future holds but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope,' he said. 'We are focused on rebuilding the life we thought we had lost and enjoying being parents'. The trial, from University College London Hospital's National Hospital for Neurology and Neurosurgery, follows a previous one on the same drug which closed because of lack of recruitment. But Dame Siobhain McDonagh MP lead a fundraising campaign to raise more than £1million to cover the costs of the new trials after her sister, Baroness McDonagh, died from glioblastoma in 2023. Dame Siobhain said: 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma. 'Changing this was Margaret's final campaign and one that I have continued in her memory. 'I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial.' Dr Paul Mulholland said: 'When I met Margaret she said to me 'what can I do to support you to cure this disease?'. 'I am incredibly grateful to her and to Siobhain whose campaigning and fundraising in her sister's memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis, with most patients surviving just nine months after diagnosis. 'The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy. 'We're taking everything we have learned from previous trials into this new study and we are already planning follow-on trials. 'My aim is to find a cure for glioblastoma.' The National Brain Appeal is currently funding two posts in support of Dr Mulholland's research. Treatment will take place at the NIHR UCLH's Clinical Research Facility and at the National Hospital for Neurology and Neurosurgery.

Diet that sheds weight fast by eating MORE: This easy plan was made to help cancer patients - then doctors realised its amazing benefits. JANE ALEXANDER tried it and couldn't believe how much she lost...
Diet that sheds weight fast by eating MORE: This easy plan was made to help cancer patients - then doctors realised its amazing benefits. JANE ALEXANDER tried it and couldn't believe how much she lost...

Daily Mail​

timean hour ago

  • Daily Mail​

Diet that sheds weight fast by eating MORE: This easy plan was made to help cancer patients - then doctors realised its amazing benefits. JANE ALEXANDER tried it and couldn't believe how much she lost...

At the age of 65, I have reached crunch point. I'm sick to the back teeth of weird diets and I'm seriously fed up with feeling hungry. I'm also really hacked off at still being fat. It's not just how I look – my GP has told me I really need to lose my stores of visceral fat (the pernicious fat around the organs in the abdomen that is so bad for our health).

New AI tool could speed up skin cancer diagnoses in remote parts of world
New AI tool could speed up skin cancer diagnoses in remote parts of world

The Independent

time2 hours ago

  • The Independent

New AI tool could speed up skin cancer diagnoses in remote parts of world

A researcher at a Scottish university has developed AI tools that could give people in remote areas of the world access to fast and potentially life-saving skin cancer diagnoses. Tess Watt, the PhD student at Heriot-Watt University in Edinburgh who led the project to develop the technology, said it is intended to enable early detection of skin conditions anywhere in the world, and without the need for direct access to dermatologists. The technology also works without internet access. The system involves a patient taking a photograph of their skin complaint using a small camera attached to a Raspberry Pi device – a cheap, energy-efficient handheld computer that is capable of storing vast amounts of information. The photograph is analysed in real-time using the latest state-of-the-art image classification, comparing it to an enormous dataset of thousands of images stored on the device to reach a diagnosis. The findings are then shared with a local GP service to begin a suitable treatment plan. The project is understood to be the first of its kind to combine AI medical diagnosis with the aim of serving remote communities. Ms Watt explained: ' Healthcare from home is a really important topic at the moment, especially as GP wait times continue to grow. 'If we can empower people to monitor skin conditions from their own homes using AI, we can dramatically reduce delays in diagnosis.' A prototype of the device has already been demonstrated at Heriot-Watt's advanced health and care technologies suite. The research team said the tool is up to 85% accurate in its diagnostic capabilities, but they hope to increase this further by gaining access to more skin lesion datasets, aided by advanced machine tools. Ms Watt is also in talks with NHS Scotland to begin the ethical approval process for testing the technology in real-world clinical settings. 'Hopefully in the next year or two, we'll have a pilot project under way,' she said, noting medical technology often takes years to move from prototype to implementation. She added: 'By the time I finish my PhD, three years from now, I'd love to see something well into the pipeline that's on its way to real-world use.' The university said the long-term vision is to roll the system out first across remote regions of Scotland, before expanding to global areas with limited access to dermatological care. It added the technology could also offer vital support to patients who are infirm or unable to travel, allowing loved ones to assist with capturing and submitting diagnostic images to GPs. Ms Watt's academic supervisor, Dr Christos Chrysoulas, said: 'E-health devices must be engineered to operate independently of external connectivity to ensure continuity of patient service and safety. 'In the event of a network or cloud service failure, such devices must fail safely and maintain all essential clinical operations without functional degradation. 'While auxiliary or non-critical features may become temporarily unavailable, the core diagnostic and even therapeutic capabilities must remain fully operational, in compliance of course with safety and regulatory requirements. 'Ensuring this level of resilience in affordable, low-cost medical devices is the essence of our research, particularly for deployment in resource-limited settings and areas with limited or no connectivity, where uninterrupted patient care must still be guaranteed.' UK Science and Technology Secretary Peter Kyle commented on the research, saying: 'Low-cost technology which could help detect skin cancer early and at home, without even the need for internet access, is an incredible example of AI's potential to break down barriers in healthcare and save lives. 'Promising, first of its kind research like this also demonstrates the crucial role UK innovators can play in improving the lives of people of all backgrounds, wherever they live, and makes clear the value of government investing in research to deliver our plan for change.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store